logo
Alberta rainy day Heritage Fund hits $30B after injection of $2.8B from surplus

Alberta rainy day Heritage Fund hits $30B after injection of $2.8B from surplus

Yahoo4 days ago
EDMONTON — Alberta's rainy-day Heritage Fund is getting an extra $2.8 billion, hitting a record high of $30 billion, which is almost double what it was five years ago.
Alberta Premier Danielle Smith's government wants it to hit $250 billion by 2050 so future governments can spend investment returns without draining the fund.
Smith says it's still on track to hit that benchmark in 25 years.
The aim is to shield Alberta's budget from the resource revenue roller coaster that has plagued past budgets.
The latest investment comes from a cash surplus of more than $5 billion that the province can spend out of an $8.3 billion bottom line surplus from the last fiscal year.
Horner says because past governments raided the piggy bank, the province missed out on hundreds of billions of dollars in returns.
"We know from the past that the fund cannot be beneficial if we do not have a strong framework to retain income in the fund and contribute when we can," he said Friday.
This report by The Canadian Press was first published July 18, 2025.
Lisa Johnson, The Canadian Press
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons
Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons

Yahoo

time7 minutes ago

  • Yahoo

Trailhead Biosystems® Expands Human Cell-Based Product Line with iPSC-Derived A9 Dopaminergic Neurons

BEACHWOOD, Ohio, July 23, 2025 /CNW/ -- Trailhead Biosystems, Inc. ( a biotechnology company pioneering the creation of induced pluripotent stem cell (iPSC)-derived human cells at scale for drug discovery and cell therapy, introduces TrailBio® A9 Dopaminergic Neurons, a powerful new tool available off-the-shelf for studying Parkinson's disease and other neurodegenerative conditions. A9 dopaminergic neurons play a critical role in movement regulation and are disproportionately affected in Parkinson's disease. Historically, researchers have lacked access to viable human models, relying instead on animal studies with limited relevance. With TrailBio® A9 Dopaminergic Neurons, scientists now have a human-specific platform to investigate disease mechanisms, develop therapies and accelerate drug discovery. "TrailBio® A9 Dopaminergic Neurons open new possibilities for Parkinson's research," said Dr. Jan Jensen, Chief Scientific Officer, Chief Technology Officer and founder of Trailhead Biosystems. "These cells enable researchers to study the vulnerabilities of A9 neurons, helping drive progress toward more effective treatments." "For decades, the lack of human A9 neurons has limited our ability to truly understand Parkinson's disease," added Dr. Nooshin Amini, Scientific Director at Trailhead Biosystems. "Now, with TrailBio® A9 Dopaminergic Neurons, researchers can directly study the exact cells that are most affected, offering hope for groundbreaking insights and future therapies." About Trailhead Biosystems Trailhead Biosystems, Inc. is pioneering an informatics-based approach in regenerative medicine and drug discovery. Founded in 2015 as a spinout from the Cleveland Clinic and Case Western Reserve University, Trailhead emerged from the research of CSO/CTO and founder Dr. Jan Jensen. Trailhead creates optimized human cells at scale with its proprietary High-Dimensional Design-of-Experiments (HD-DoE®) platform, integrating advanced mathematical modeling with high-throughput robotic manufacturing. This innovative system allows Trailhead to develop specialized, high-quality iPSC-derived human cells for drug discovery and cell-based therapies. TrailBio® A9 Dopaminergic Neurons represent one of many specialized human cell types emerging from this platform, with additional cell models expected in the near future. Learn more about Trailhead Biosystems, TrailBio® A9 Dopaminergic Neurons and HD-DoE® at For more information, please contact: Tim Mauk, Corporate CommunicationsTrailhead BiosystemsEmail: info@ View original content to download multimedia: SOURCE Trailhead Biosystems Inc View original content to download multimedia:

A bookstore that's been a Halifax institution since 1987 is facing closure
A bookstore that's been a Halifax institution since 1987 is facing closure

Yahoo

time7 minutes ago

  • Yahoo

A bookstore that's been a Halifax institution since 1987 is facing closure

An iconic Halifax bookstore may be forced to close permanently if the business is unable to raise enough money to catch up on rent by Friday. John W. Doull, Bookseller has been an institution in the city since 1987. It specializes in rare and out-of-print books, but carries a bit of everything and anything a bookworm could wish for. The used bookstore, which has been located on Main Street in Dartmouth since 2021, has a massive inventory that Doull recently estimated at 2 to 3 million books. If accurate, that would make the store one of the largest in Canada. But its days may be numbered. Doull didn't respond to an interview request Tuesday, but Jacob Smith — the business's only other employee — said they're two months behind on rent. They've been given notice by the building's landlord, Yellowstone Commercial Properties, that if they don't catch up by Friday, they'll be evicted. Including next month's rent, Smith estimated the store needs to bring in $15,000 to $20,000 in revenue by Friday evening. He was initially pessimistic they'd have any chance of reaching this goal, but after word circulated online that the shop was in trouble, he said business picked up. "On Monday, we did probably $4,000, $4,500 worth of sales, so if we can keep that ball rolling, it'll be good," Smith said. Prices on the entirety of the massive inventory have been discounted by 40 per cent in an attempt to draw in buyers and raise the funds. Business has picked up On Tuesday, the store was as busy as Smith had ever seen it, filled with longtime regulars and new customers. Anthony Reynolds said his partner, who'd been coming to the store since she was a kid, tipped him off about the sale after reading about the store's finances online. "She was really sad that it was closing and she knows that I love books," he said. "She told me it's like a maze so I definitely wanted to come and check it out before it closed." Former employee Jane Sodero, who first worked at the bookstore when it was located on Hollis Street in Halifax, came down shortly after hearing the news. "It's going to be such a loss to the city to not have a bookstore of this magnitude," she said. "Any book on any topic imaginable is available here." Historian Holly Hanes has been a regular since around 2018. She showed up with a list of books, many of them long out-of-print, about Nova Scotia and Newfoundland and Labrador that she was hoping to track down. It's rare, she said, for historians to be able to purchase any of this material, which is often only accessible in archives. Future unknown If the bookstore was to close, Smith said he's not sure what would happen to its inventory. He expects that many rare books and antiques would get auctioned off, but worries that much of the store's main inventory would be thrown out. Will Radford, the controller for Yellowstone Commercial Developments, said the company is willing to work with Doull if he meets Friday's deadline. But he said it's not the first time Doull has had trouble making rent. "We''re really hoping that, you know, he'll turn around the operation and be able to pay us money and continue to lease from us," he said. "If they can't pay the money at that time, then we would end up taking possession of the unit … and John Doull's business would be evicted." If it did come to that, Radford said in the short term, there are no plans to redevelop the property. Instead, the company would seek out a new tenant. MORE TOP STORIES

Texas Instruments shares sink as tariff risks cloud chip demand outlook
Texas Instruments shares sink as tariff risks cloud chip demand outlook

Yahoo

time7 minutes ago

  • Yahoo

Texas Instruments shares sink as tariff risks cloud chip demand outlook

(Reuters) -Texas Instruments shares slumped nearly 12% in premarket trading on Wednesday, after its quarterly profit forecast indicated a hit to demand for its analog chips that stoked investor fears of tariff-related disruptions. The dour third-quarter profit forecast contrasts with its earlier hopes for a strong rebound in chip demand, increasing concerns about tariff impacts and tempering investor confidence. In response to analysts' questions on a post-earnings call about whether tariffs were prompting customers to pull in orders and bumping up revenue, TI CEO Haviv Ilan said he "can't rule out the possibility". "(TI's) tone has shifted markedly vs last quarter's call as well as vs management's intra-quarter commentary, with seemingly more caution around the geopolitical and tariff environment," said Bernstein analyst, Stacy Rasgon, adding that the shift "felt somewhat sudden". Chipmakers like TI are not directly affected by Trump's higher tariffs yet, but rising costs for chip-making tools and reduced spending by some customers are starting to have an impact. This was evident in the broader semiconductor industry, with both ASML, the biggest supplier of chip-making equipment globally, and TSMC, the world's biggest chipmaking factory, last week, warned about tariff-related uncertainty. "The impact of tariffs/trade is beginning to emerge and we anticipate a continuation of a slightly weaker than seasonal demand environment as the year progresses due to the impact of tariffs," said analysts at J.P. Morgan. Some analysts also expressed concerns about pressure to TI's margins due to the company's rising investments to expand its U.S. manufacturing footprint. Following the results, at least six brokerages cut price targets on the stock, while three raised, as per data compiled by LSEG. The firm is up about 15%, while peer Analog Devices has gained around 11%, so far this year. TI has a 12-month forward price-to-earnings ratio of 34.66, compared to Analog Devices' 27.64.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store